Max N. Wallace insider trades
Open-market stock purchases and sales by Max N. Wallace, Director at Humacyte, Inc, from SEC Form 4 filings since Aug 26, 2021.
Track record: 0% of 2 scored buys are up 5% or more since purchase, averaging -78%.
Recent trades
| Date | Stock | Trade | Value |
|---|---|---|---|
| Jun 11, 2026 | HUMA Humacyte, Inc | Bought (not open market) | — |
Companies traded
- HUMA Humacyte, Inc: 2 buys, last Jun 11, 2026